Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $135.42 per share (Direct)
  Date: 2026-08-12 | Code: M | equity_swap_involved: false | shares_owned_after: 333,943.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 40 shares of Common Stock at $507.076 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 333,903.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2
• Sold 440 shares of Common Stock at $508.8598 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 333,463.00 | transaction_form_type: 4 | Footnotes: F1, F4, F2
• Sold 280 shares of Common Stock at $509.6114 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 333,183.00 | transaction_form_type: 4 | Footnotes: F1, F5, F2
• Sold 1,152 shares of Common Stock at $511.1178 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 332,031.00 | transaction_form_type: 4 | Footnotes: F1, F6, F2
• Sold 542 shares of Common Stock at $511.7471 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 331,489.00 | transaction_form_type: 4 | Footnotes: F1, F7, F2
• Sold 1,206 shares of Common Stock at $513.0168 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 330,283.00 | transaction_form_type: 4 | Footnotes: F1, F8, F2
• Sold 558 shares of Common Stock at $514.1839 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 329,725.00 | transaction_form_type: 4 | Footnotes: F1, F9, F2
• Sold 893 shares of Common Stock at $514.8746 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 328,832.00 | transaction_form_type: 4 | Footnotes: F1, F10, F2
• Sold 940 shares of Common Stock at $516.1606 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 327,892.00 | transaction_form_type: 4 | Footnotes: F1, F11, F2
• Sold 1,249 shares of Common Stock at $517.2146 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 326,643.00 | transaction_form_type: 4 | Footnotes: F1, F12, F2
• Sold 320 shares of Common Stock at $518.1566 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 326,323.00 | transaction_form_type: 4 | Footnotes: F1, F13, F2
• Sold 1,160 shares of Common Stock at $519.4888 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 325,163.00 | transaction_form_type: 4 | Footnotes: F1, F14, F2
• Sold 679 shares of Common Stock at $520.3779 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 324,484.00 | transaction_form_type: 4 | Footnotes: F1, F15, F2
• Sold 41 shares of Common Stock at $520.9598 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: false | shares_owned_after: 324,443.00 | transaction_form_type: 4 | Footnotes: F1, F16, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: H | shares_owned_after: 40,513.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 249,108.00 | Footnotes: F17
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F18
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 8,902.00 | Footnotes: F19
• Sold 9,500 shares of Stock Option at $135.42 per share (Derivative)
  Date: 2026-08-12 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 151,410.00 | transaction_form_type: 4 | Footnotes: F1, F20

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
• F10: This transaction was executed in multiple trades at prices ranging from $514.63 to $515.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $515.63 to $516.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: This transaction was executed in multiple trades at prices ranging from $516.63 to $517.625. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F13: This transaction was executed in multiple trades at prices ranging from $517.66 to $518.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F14: This transaction was executed in multiple trades at prices ranging from $518.92 to $519.885. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F15: This transaction was executed in multiple trades at prices ranging from $519.92 to $520.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F16: This transaction was executed in multiple trades at prices ranging from $520.95 to $520.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F17: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F18: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F19: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F20: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
• F3: This transaction was executed in multiple trades at prices ranging from $506.59 to $507.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $508.24 to $509.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $509.39 to $510.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $510.45 to $511.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $511.46 to $512.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $512.46 to $513.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $513.55 to $514.525. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.